If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForesight Solar Fund Regulatory News (FSFL)

Share Price Information for Foresight Solar Fund (FSFL)

Share Price is delayed by 15 minutes
Get Live Data
71.90    1.70 (2.42%)
Bid:
71.50
Ask:
72.00
Spread: 0.50 (0.699%)
Market Cap: £392.20m
FSFL Live PriceLast checked at - London Stock Exchange

Intraday Foresight Solar Fund Share Chart

Scrip Share Price

3 Feb 2022 11:16

RNS Number : 6295A
Foresight Solar Fund Limited
03 February 2022
 

FSFL3 February 2022

Foresight Solar Fund Limited

("Foresight Solar" or "the Company")

Scrip Share Price

The reference price of a new Ordinary Share under the Company's scrip dividend alternative for the second quarterly interim dividend for the financial period ending 30 September June 2021 (the "Q3 Dividend") has been set at 100.60 pence. This is the average of the middle market prices of the Company's Ordinary Shares derived from the London Stock Exchange Daily Official List for the ex-dividend date and the four subsequent dealing days.

Further information regarding the scrip dividend offered in respect of the Q3 Dividend and the Scrip Dividend Scheme can be found in the Scrip Dividend Alternative Offer (the "Scrip Offer") available on the Company's website to view and/or download at fsfl.foresightgroup.eu/investor-relations/. The Scrip Offer is also available on the National Storage Mechanism website at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. Copies of the Scrip Offer will also be available for inspection at 28 Esplanade, St. Helier, Jersey JE2 3QA.

If no elections for the Scrip Dividend Option are received, the total cash dividend payable by the Company would be £10,640,554.83.

If all eligible Shareholders elected, under the Scrip Dividend Option, to receive the Dividend in the form of New Shares rather than in cash in respect of their entire holdings, 10,577,092 New Shares would be issued (ignoring any reduction in respect of fractions), representing approximately 1.73% of the issued Ordinary Share capital of the Company as at today's date.

The Q3 Dividend payment date and the date for admission and dealing of the New Ordinary Shares to be issued pursuant to the scrip dividend alternative is expected to be 28 February 2022.

For further information, please contact:

Foresight GroupNish SivarajanInstitutionalIR@ForesightGroup.eu

+44 (0)20 3911 2318

Jefferies International Limited

Neil Winward

Gaudi Le Roux

+44 (0)20 7029 8000

 

 

Citigate Dewe Rogerson Toby MooreElizabeth Kittle Lucy Eyles

 

+44 (0)20 7638 9571

JTC (Jersey) Limited Christopher GibbonsForesightsolar@jtcgroup.com

+44 (0)203 846 9774

 

LEI: 213800VO4O83JVSSOX33

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVMZGGZMFVGZZM
Date   Source Headline
25th Sep 20255:04 pmRNSTransaction in Own Shares
23rd Sep 20255:14 pmRNSDirector/PDMR Shareholding
23rd Sep 20254:16 pmRNSTransaction in Own Shares
22nd Sep 20254:32 pmRNSTransaction in Own Shares
19th Sep 20254:57 pmRNSTransaction in Own Shares
18th Sep 20254:36 pmRNSTransaction in Own Shares
18th Sep 20257:00 amRNSInterim results to 30 June 2025
17th Sep 20254:13 pmRNSTransaction in Own Shares
17th Sep 20257:00 amRNSDividend Declaration - Replacement
16th Sep 20254:52 pmRNSTransaction in Own Shares
16th Sep 20254:34 pmRNSDirectorate Change
16th Sep 20252:55 pmRNSDividend Declaration
15th Sep 20254:55 pmRNSTransaction in Own Shares
12th Sep 20254:55 pmRNSTransaction in Own Shares
10th Sep 20255:04 pmRNSTransaction in Own Shares
9th Sep 20254:56 pmRNSTransaction in Own Shares
8th Sep 20255:10 pmRNSTransaction in Own Shares
5th Sep 20254:58 pmRNSTransaction in Own Shares
2nd Sep 20254:20 pmRNSTransaction in Own Shares
2nd Sep 20253:38 pmRNSHolding(s) in Company
1st Sep 20254:59 pmRNSTransaction in Own Shares
29th Aug 20255:03 pmRNSTotal Voting Rights
29th Aug 20254:54 pmRNSTransaction in Own Shares
28th Aug 20255:00 pmRNSTransaction in Own Shares
27th Aug 20254:50 pmRNSTransaction in Own Shares
27th Aug 20257:00 amRNSBattery Portfolio Update
26th Aug 20255:06 pmRNSTransaction in Own Shares
22nd Aug 20254:48 pmRNSTransaction in Own Shares
21st Aug 20253:47 pmRNSTransaction in Own Shares
20th Aug 20255:02 pmRNSTransaction in Own Shares
19th Aug 20254:56 pmRNSTransaction in Own Shares
18th Aug 20254:53 pmRNSTransaction in Own Shares
18th Aug 20257:00 amRNSNotice of Results
15th Aug 20254:51 pmRNSTransaction in Own Shares
14th Aug 20254:50 pmRNSTransaction in Own Shares
13th Aug 20254:52 pmRNSTransaction in Own Shares
12th Aug 20254:55 pmRNSTransaction in Own Shares
11th Aug 20254:57 pmRNSTransaction in Own Shares
8th Aug 20254:56 pmRNSTransaction in Own Shares
7th Aug 20255:06 pmRNSTransaction in Own Shares
6th Aug 20255:04 pmRNSTransaction in Own Shares
6th Aug 20257:00 amRNSQ2 2025 Net Asset Value and Trading Update
5th Aug 20254:51 pmRNSTransaction in Own Shares
5th Aug 202512:28 pmRNSHolding(s) in Company
4th Aug 20254:57 pmRNSTransaction in Own Shares
1st Aug 20254:54 pmRNSTransaction in Own Shares
31st Jul 20255:01 pmRNSTotal Voting Rights
31st Jul 20254:55 pmRNSTransaction in Own Shares
30th Jul 20256:19 pmRNSHolding(s) in Company
29th Jul 20254:53 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.